FILANA THERAPEUTICS, INC. - Common Stock (SAVA)

CUSIP: 14817C107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock
Shares outstanding
48,331,225
Total 13F shares
11,593,879
Share change
-2,303,353
Total reported value
$235,338,414
Put/Call ratio
69%
Price per share
$20.29
Number of holders
141
Value change
-$49,008,344
Number of buys
57
Number of sells
65

Quarterly Holders Quick Answers

What is CUSIP 14817C107?
CUSIP 14817C107 identifies SAVA - FILANA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FILANA THERAPEUTICS, INC. - Common Stock (SAVA) as of Q1 2024

As of 31 Mar 2024, FILANA THERAPEUTICS, INC. - Common Stock (SAVA) was held by 141 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,593,879 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Gallacher Capital Management LLC, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, MORGAN STANLEY, NORGES BANK, and Nuveen Asset Management, LLC. This page lists 141 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.